The field of Cell Therapies has seen major advances in recent years in the treatment of cancers. These therapies include immune cells that are engineered or selected to have specific tumor targeting ability, or are primed to induce an immune response, including examples such as CARTs and NK cell therapies. The field of cell therapies is rapidly evolving with new agents, manufacturing processes, and novel biological mechanisms in active development.
Oncology Resource Group (ONCrg) is a team of expert analysts who rigorously evaluate the latest corporate reports, news, and data presentations to distill out important advances in complex therapeutic areas. Our comprehensive medical congress coverage, and continuous market surveillance put these advances into the context of an overarching competitive landscape in cell therapies to help guide strategic and tactical commercial development decisions for market participants.